Actress Sofia Vergara is helping to raise awareness about the importance of diagnosing and treating hypothyroidism — and adhering to prescribed medications — through a new campaign sponsored by AbbVie.
Coca-Cola Co. has added a no-caffeine product to its Coke Zero soft drink line. The beverage giant said Wednesday that the new Caffeine Free Coke Zero, which has no calories, gives consumers "a great-tasting option for later-in-the-day consumption.
SymphonyIRI Group Inc. is returning to its founding name of Information Resources Inc. and rebranding as IRI.
Dr. Pepper Snapple Group has announced "Be the Next /1," a national consumer contest that offers fans the chance to star in upcoming national television commercials and digital advertising for the Dr. Pepper soft drink brand.
Frito-Lay North America has extended its Lay’s Wavy potato chip line with the introduction of Lay’s Wavy Garlic & Sea Salt. The PepsiCo snack subsidiary said the new Lay’s Wavy Roasted Garlic & Sea Salt potato chips will be available in stores nationwide this month in a 9.5-ounce bag for a suggested
Taro Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for Topicort Topical Spray 0.25%. The company said Friday that the Topicort (desoximetasone) spray, a corticosteroid, is indicated for the treatment of plaque psoriasis in patients age 18 and older.
Warner Chilcott has been cleared by the Food and Drug Administration to market 200-mg strength of Doryx delayed-release tablets. The Ireland-based pharmaceutical company said Friday that it expects the commercial launch of the Doryx tablets to take place in July.
PuraMed BioScience Inc. plans to ramp up the retail sales efforts for its LipiGesic M homeopathic migraine headache remedy by targeting another 21,000 retail outlets.
Chattem Inc. has extended its Allegra allergy brand with a pair of topical anti-itch creams.
Actavis Inc. plans to launch generic versions of Ziana and Zyclara through an agreement with Medicis Pharmaceutical Corp., a subsidiary of Valeant Pharmaceuticals International Inc.
ImmuneTech Inc. has introduced MyAllergyTest, which the company calls the first Food and Drug Administration-cleared, at-home test that allows allergy sufferers to test themselves for 10 key allergens, ranging from food and environmental to inhalants and animal.
Astroglide has launched Astroglide Sensitive Skin Gel, described as a thicker personal lubricant that’s formulated without common ingredients known to irritate sensitive skin. BioFilm Inc.
Dr. Reddy’s Laboratories plans to relocate its North America headquarters and establish a research and development center in Princeton, N.J.
Culturelle has launched an adult-strength chewable version of its probiotic supplement. The company said Monday that Culturelle Digestive Health Probiotic Chewables enable easier daily probiotic consumption for the many adults who have difficulty swallowing pills.
AllergEase has begun rolling out an all-natural herbal lozenge that provides relief to allergy sufferers.
Mylan Inc. has released acyclovir ointment 5%, an antiviral medication for the treatment of herpes. The company said Wednesday that its product is is the first generic version of Valeant Pharmaceuticals’ Zovirax Ointment.
